Trademark: 86014025
Word
OBI PHARMA
Status Date
Saturday, April 2, 2022
Registration Number
4737391
Registration Date
Tuesday, May 19, 2015
Filing Date
Thursday, July 18, 2013
Published for Opposition
Tuesday, March 3, 2015
5 Antibiotic preparations; Antibiotics; Anti-cancer preparations; Anti-infectives; Anti-inflammatories; Biological preparations for the treatment of cancer; Chemical reagents for medical or veterinary purposes; Diagnostic agents, preparations and substances for medical purposes; Diagnostic kits consisting primarily of monoclonal antibodies, buffers and reagents for use in disease testing; Diagnostic preparations for medical and veterinary use; Diagnostic preparations for medical or veterinary purposes; Diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; Diagnostic preparations for medical purposes; Diagnostic radiopharmaceutical preparations; Diagnostic reagents for medical use; Diagnostic reagents and contrast media for medical use; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Gastro-intestinal treatment preparations; In-vivo diagnostic agent used for detection and monitoring of angiogenesis and anti-angiogenic therapy; Medical diagnostic reagents and assays for testing body fluids; Medical diagnostic reagents and assays for testing body fluids for microorganisms; Medical diagnostic reagents for the analysis of body fluids; Medicinal preparations for the treatment of infectious diseases and for using in oncology; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; Reagents and media for medical and veterinary diagnostic purposes; Reagents for medical use; Vaccine adjuvants; Vaccine preparations; Vaccine stabilizers; Vaccines
The mark consists of the letters "OBI", with the letter "O" in teal and light teal and in the form of a spinning wheel, with the letters "BI" in teal. Beneath these letters is a curved line in teal. Beneath the curved line is the term "PHARMA" in teal.
The color(s) teal and light teal is/are claimed as a feature of the mark.
"PHARMA"
Jul 24, 2013
New Application Office Supplied Data Entered
Jul 25, 2013
Notice Of Design Search Code E-Mailed
Jul 22, 2013
New Application Entered
Mar 20, 2014
Correspondence Received In Law Office
Aug 6, 2013
Teas Voluntary Amendment Received
Aug 7, 2013
Teas Voluntary Amendment Received
Aug 7, 2013
Teas Amendment Entered Before Attorney Assigned
Oct 31, 2013
Assigned To Examiner
Nov 6, 2013
Non-Final Action Written
Nov 6, 2013
Non-Final Action E-Mailed
Nov 6, 2013
Notification Of Non-Final Action E-Mailed
Mar 20, 2014
Teas Response To Office Action Received
Mar 21, 2014
Teas/Email Correspondence Entered
Jul 16, 2014
Non-Final Action E-Mailed
Mar 21, 2014
Suspension Letter Written
Mar 21, 2014
Letter Of Suspension E-Mailed
Mar 21, 2014
Notification Of Letter Of Suspension E-Mailed
Jun 25, 2014
Teas Response To Suspension Inquiry Received
Jul 4, 2014
Assigned To Lie
Jul 9, 2014
Correspondence Received In Law Office
Jul 9, 2014
Teas/Email Correspondence Entered
Jul 16, 2014
Non-Final Action Written
Jul 16, 2014
Notification Of Non-Final Action E-Mailed
Jan 20, 2015
Approved For Pub - Principal Register
Feb 11, 2015
Notification Of Notice Of Publication E-Mailed
Mar 3, 2015
Published For Opposition
Mar 3, 2015
Official Gazette Publication Confirmation E-Mailed
May 19, 2015
Registered-Principal Register
May 2, 2019
Teas Change Of Correspondence Received
May 19, 2020
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Sep 24, 2021
Teas Section 8 Received
Jan 15, 2015
Teas Response To Office Action Received
Jan 15, 2015
Correspondence Received In Law Office
Jan 15, 2015
Teas/Email Correspondence Entered
Jan 26, 2015
Law Office Publication Review Completed
Apr 2, 2022
Registered - Sec. 8 (6-Yr) Accepted
Mar 27, 2024
Teas Change Of Owner Address Received
Apr 2, 2022
Case Assigned To Post Registration Paralegal
Apr 2, 2022
Notice Of Acceptance Of Sec. 8 - E-Mailed
Mar 27, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
Mar 27, 2024
Applicant/Correspondence Changes (Non-Responsive) Entered
Mar 27, 2024
Teas Change Of Correspondence Received
Mar 27, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
May 19, 2024
Courtesy Reminder - Sec. 8 (10-Yr)/Sec. 9 E-Mailed
Mar 27, 2024
Teas Withdrawal As Domestic Representative Received
Trademark Alertz updated from USPTO on 2030-01-24
